Table 4.
Histologic classification of IPMN | First author | Tissue Source | Up-regulated | Down-regulated |
---|---|---|---|---|
Lesion | ||||
Non-invasive IPMN | Habbel97, Caponi94, Nakhara98 |
Tissue | miR-21, miR-155, miR-107, miR-223, miR-181c, miR-181a, miR-221, miR-210, miR-16, miR-100 |
miR-101 |
Li99 | Serum | miR-1290 | -- | |
Invasive IPMN | Lubezky95, Caponi94, He100 |
Tissue | miR-21, miR-155, miR-708 |
miR-101, miR-217, miR-218 |
PDAC vs non-invasive IPMN | Lee101 | Tissue | miR-21-5p, miR-708 | miR-485-3p, miR- 375 |
Jiao102 | Tissue | miR-16, miR-126 | ||
Li99 | Serum | miR-1290 | -- | |
Degree of dysplasia | ||||
HG IPMN | Lubezky95, Habbe97 | Tissue | miR-10a, miR-21, miR-146, miR-155 |
-- |
IG IPMN | Lubezky95, Habbe97 | Tissue | miR-21, miR-155, miR-708 |
miR-217 |
LG IPMN | Lubezky95, Habbe97 | Tissue | miR-21, miR-155, miR-708 |
miR-217 |
HG/Invasive IPMN vs LG/IG IPMN |
Lubezky95 | Tissue | miR-21, miR-146a, miR-150, miR-214, miR-503, miR-424, miR-708, miR-155 |
miR-217, miR-216a, miR-216b, miR-148, miR-375, miR-130b |
Matthei96 | Tissue, cyst fluid | miR-18a, miR-24, miR-30a-3p, miR- 92a, miR-99b miR- 106b, miR-142-3p, miR-342-3p, miR- 532-3p |
DiffPairs analysis | |
LG IPMN vs HG IPMN with evidence of invasion |
Lubezky96 | Tissue | miR-10a, miR-21, miR-24-2, miR-132, miR-146a, miR-146b, miR-155, miR-196, miR-424, miR-503, miR-708 |
miR-217, miR-216a, miR-216b, miR-148, miR-375, miR-130b |
IPMN morphological subtype | ||||
Intestinal | Aso103, Habbe97 | Tissue, serum | miR-196a, miR-21, miR-155 |
-- |
Gastric | Habbe97 | Tissue | -- | miR-155 |
IPMN, intraductal papillary mucinous neoplasm; HG, high grade; IG, intermediate grade; LG, low grade; PDAC, pancreatic ductal adenocarcinoma.